These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37977354)

  • 1. Interleukin-1 receptor antagonist: An alternative therapy for cancer treatment.
    Fang Z; Jiang J; Zheng X
    Life Sci; 2023 Dec; 335():122276. PubMed ID: 37977354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PASylation of IL-1 receptor antagonist (IL-1Ra) retains IL-1 blockade and extends its duration in mouse urate crystal-induced peritonitis.
    Powers NE; Swartzwelter B; Marchetti C; de Graaf DM; Lerchner A; Schlapschy M; Datar R; Binder U; Edwards CK; Skerra A; Dinarello CA
    J Biol Chem; 2020 Jan; 295(3):868-882. PubMed ID: 31819009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury.
    Lindblad C; Rostami E; Helmy A
    Neurotherapeutics; 2023 Oct; 20(6):1508-1528. PubMed ID: 37610701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis.
    Volarevic V; Al-Qahtani A; Arsenijevic N; Pajovic S; Lukic ML
    Autoimmunity; 2010 Jun; 43(4):255-63. PubMed ID: 19845478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease.
    Vijmasi T; Chen FY; Chen YT; Gallup M; McNamara N
    Mol Vis; 2013; 19():1957-65. PubMed ID: 24068863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable biomaterials for delivery of interleukin-1 receptor antagonist: Toward improving its therapeutic effect.
    Clements AEB; Murphy WL
    Acta Biomater; 2019 Jul; 93():123-134. PubMed ID: 31029831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why not treat human cancer with interleukin-1 blockade?
    Dinarello CA
    Cancer Metastasis Rev; 2010 Jun; 29(2):317-29. PubMed ID: 20422276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer.
    Gong Z; Ma J; Su H; Guo T; Cai H; Chen Q; Zhao X; Qi J; Du J
    Int J Clin Oncol; 2018 Aug; 23(4):659-670. PubMed ID: 29344744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interleukin-1/interleukin-1 receptor antagonist family of cytokines in long-term continuous glucose monitoring in vivo.
    Klueh U; Antar O; Qiao Y; Kreutzer DL
    J Diabetes Sci Technol; 2013 Nov; 7(6):1538-46. PubMed ID: 24351180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DIRA: life-threatening but treatable inherited inflammatory disease].
    ter Haar NM; van Royen A; van Gijn ME; Frenkel J
    Ned Tijdschr Geneeskd; 2010; 154():A1601. PubMed ID: 20482912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancer.
    Kopp WC; Urba WJ; Rager HC; Alvord WG; Oppenheim JJ; Smith JW; Longo DL
    Clin Cancer Res; 1996 Mar; 2(3):501-6. PubMed ID: 9816196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 Trial.
    Smith CJ; Hulme S; Vail A; Heal C; Parry-Jones AR; Scarth S; Hopkins K; Hoadley M; Allan SM; Rothwell NJ; Hopkins SJ; Tyrrell PJ
    Stroke; 2018 May; 49(5):1210-1216. PubMed ID: 29567761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.
    Kalliolias GD; Liossis SN
    Expert Opin Investig Drugs; 2008 Mar; 17(3):349-59. PubMed ID: 18321234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1β receptor antagonist reduces inflammation in hemodialysis patients.
    Hung AM; Ellis CD; Shintani A; Booker C; Ikizler TA
    J Am Soc Nephrol; 2011 Mar; 22(3):437-42. PubMed ID: 21310819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating inflammation by blocking interleukin-1 in humans.
    Dinarello CA; van der Meer JW
    Semin Immunol; 2013 Dec; 25(6):469-84. PubMed ID: 24275598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 receptor antagonist.
    Lennard AC
    Crit Rev Immunol; 1995; 15(1):77-105. PubMed ID: 8519423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis.
    Gorelik M; Lee Y; Abe M; Andrews T; Davis L; Patterson J; Chen S; Crother TR; Aune GJ; Noval Rivas M; Arditi M
    Clin Exp Immunol; 2019 Oct; 198(1):101-110. PubMed ID: 31099056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anakinra Pilot - a clinical trial to demonstrate safety, feasibility and pharmacokinetics of interleukin 1 receptor antagonist in preterm infants.
    Green EA; Metz D; Galinsky R; Atkinson R; Skuza EM; Clark M; Gunn AJ; Kirkpatrick CM; Hunt RW; Berger PJ; Nold-Petry CA; Nold MF
    Front Immunol; 2022; 13():1022104. PubMed ID: 36389766
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.